MYCN and neuroblastoma: Based on our data, depletion of PDPK1 in CHP-134 cells does not impact steady-state protein levels of N-MYC (Fig. 2a) as has been seen for shRNA-mediated knockdown or chemical inhibition of PLK1 in neuroblastoma cells [25].